Seaport Global upgrades Ralliant to Buy, sets $88 price target

Seaport Global upgraded Ralliant Corp to Buy with a $88.00 price target, implying 21.0% upside from the Oct 13 close. The analyst cites strong sales, earnings performance, and an optimistic outlook with improved earnings estimates for 2026 and 2027, driven by effective execution and cost reductions.

Original reporting
Published Oct 14, 2026, 11:19 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Seaport Global upgrades Ralliant to Buy, sets $88 price target — source image
Decision brief

The 30-second read

Med
01

Why it matters

The new target raises expectations for earnings growth and margin expansion, likely attracting buy‑side interest.

02

Market read

A fresh upgrade on a micro‑cap can generate notable price movement, especially with a sizable upside target.

03

What to watch

Potential macro headwinds in the end‑market demand could limit margin improvements.

Relevance 7/10Novelty 8/10Timing: immediate today

Background

Ralliant Corp is a small‑cap industrial services company; analyst upgrades can move thinly traded stocks.

Market effects

Positive signal for the industrial services sector, may lift peers.

Limited to U.S. equities where Ralliant trades.

Low

Counterpoint

The upgrade may be premature if earnings growth does not meet revised estimates.

Key entities

  • Seaport Global

    Research firm that issued the upgrade and price target.

  • Ralliant Corp

    Subject of the upgrade; ticker RLT.

Related articles

$RALMed

Evercore ISI raises Ralliant stock price target on margin outlook

Evercore ISI raised its price target for Ralliant Corp. to $85.00, citing improved margin projections for its sensors & safety systems segment. The firm increased its 2027-28 adjusted EBITA and EPS estimates, which are above consensus. Ralliant's Q2 2026 earnings beat expectations, with revenue up 13% and EBITDA margin improving by 390 basis points. The company also raised its full-year 2026 outlook.

$BBAIHigh

Cantor Fitzgerald cuts BigBear.ai stock price target on execution concerns

Cantor Fitzgerald reduced its price target on BigBear.ai (BBAI) to $3.00 from $4.00, citing execution concerns. The stock is down 65% over the past year. BigBear.ai reported Q3 revenue of $43.6M, up 31.5% YoY, but adjusted EBITDA was negative $9.1M. The company raised its fiscal 2026 revenue guidance to $150M-$165M. Analysts do not expect profitability this year, with EPS forecast at -$0.03 for FY2026.

$MRNAHigh

Why is Moderna stock rebounding today?

Moderna (MRNA) stock rose 3.1% to $214.41 after positive Phase 3 trial data for its cancer vaccine was presented, showing a 42% reduction in melanoma recurrence risk. Piper Sandler raised its price target to $230, countering a prior downgrade. Analysts remain divided, with a consensus 'Hold' rating. The stock had fallen 18% the prior week. Earnings are due November 6.